Literature DB >> 20212064

Neuroethical issues in cognitive enhancement.

Barbara J Sahakian1, Sharon Morein-Zamir.   

Abstract

Neuroethics is a developing field, concerned with addressing present and future applied ethical issues brought about directly and indirectly by neuroscience advancements. One domain where neuroscience has begun to have far-reaching ethical implications is in the research and development of pharmaceutical cognitive enhancers. Though such drugs are typically developed to treat cognitive disabilities and improve the quality of life for patients with neuropsychiatric disorders and brain injury, research has found that such drugs can improve performance on cognitive tasks in healthy individuals. In line with such findings is the growing use of these drugs by students and others for cognitive-enhancing purposes. The present paper reviews some of the evidence in both neuropsychiatric and healthy individuals and discusses the implications such research can have for society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20212064     DOI: 10.1177/0269881109106926

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  22 in total

1.  "This drug turned me into a robot": an actor-network analysis of a web-based ethnographic study of psychostimulant use.

Authors:  Caroline Robitaille
Journal:  Can J Public Health       Date:  2018-11-21

2.  Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons.

Authors:  A Bari; G Aston-Jones
Journal:  Neuropharmacology       Date:  2012-07-20       Impact factor: 5.250

Review 3.  The likelihood of cognitive enhancement.

Authors:  Gary Lynch; Linda C Palmer; Christine M Gall
Journal:  Pharmacol Biochem Behav       Date:  2011-01-06       Impact factor: 3.533

Review 4.  Cognitive enhancers for the treatment of ADHD.

Authors:  L Cinnamon Bidwell; F Joseph McClernon; Scott H Kollins
Journal:  Pharmacol Biochem Behav       Date:  2011-05-10       Impact factor: 3.533

Review 5.  The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.

Authors:  Maddalena Mereu; Antonello Bonci; Amy Hauck Newman; Gianluigi Tanda
Journal:  Psychopharmacology (Berl)       Date:  2013-08-10       Impact factor: 4.530

6.  Toward a Method for Exposing and Elucidating Ethical Issues with Human Cognitive Enhancement Technologies.

Authors:  Bjørn Hofmann
Journal:  Sci Eng Ethics       Date:  2016-07-04       Impact factor: 3.525

7.  Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.

Authors:  Renee A Rotolo; Predrag Kalaba; Vladimir Dragacevic; Rose E Presby; Julia Neri; Emily Robertson; Jen-Hau Yang; Merce Correa; Vasiliy Bakulev; Natalia N Volkova; Christian Pifl; Gert Lubec; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2020-08-07       Impact factor: 4.530

8.  The Downsides of Cognitive Enhancement.

Authors:  Lorenza S Colzato; Bernhard Hommel; Christian Beste
Journal:  Neuroscientist       Date:  2020-07-30       Impact factor: 7.519

9.  Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers.

Authors:  U Müller; J B Rowe; T Rittman; C Lewis; T W Robbins; B J Sahakian
Journal:  Neuropharmacology       Date:  2012-07-20       Impact factor: 5.250

Review 10.  Research Review: Emanuel Miller Memorial Lecture 2012 - neuroscientific studies of intervention for language impairment in children: interpretive and methodological problems.

Authors:  D V M Bishop
Journal:  J Child Psychol Psychiatry       Date:  2013-01-02       Impact factor: 8.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.